| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8442357 | European Journal of Cancer | 2015 | 7 Pages |
Abstract
Our results suggest that combination chemotherapy with S-1 and bevacizumab can be administered safely and continuously on an outpatient basis and is therapeutically effective in elderly patients with mCRC.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
M. Yoshida, K. Muro, A. Tsuji, Y. Hamamoto, T. Yoshino, K. Yoshida, K. Shirao, Y. Miyata, D. Takahari, T. Takahashi, A. Ohtsu,